life.
science.
discovery.

Customer Update – COVID-19

MBL International has been actively monitoring COVID-19 developments and want to assure you that the safety of our team and our customers is our primary focus. The COVID-19 pandemic presents a very fluid situation with challenges for each of us.

Learn more about how MBL International is responding to the safety of our employees and needs of our customers.

Download our most recent  Webinars!

Explore our video library of webinars as well as register for our upcoming webinars that focus on different life science research topics and applications.

• QuickSwitch™ Peptide Screening Kit – Quickly quantitate peptide-MHC binding affinity
• QuickSwitch™ HLA-A*03:01 Tetramer Kits – Quickly generate new high-quality tetramer specificities
• SARS-CoV2 Tetramers – Targeted T-cell detection for SARS-CoV2 immune detection
• Magnosphere™ Magnetic Beads – Magnetic beads for life sciences research
• Immutex™ Latex Beads– Variety of particle sizes and surface chemistries are available
• QuickSwitch™ HLA-A*11:01 Tetramer Kits – Generate new high-quality tetramer specificities quickly!
• T-Select Human MR1 Tetramer – Use to recognize human MAIT cells binding to MR1/MR1-ligand complex

• Human MHC Class II QuickSwitch™ Platform is used to Identify SARS-CoV-2 Virus Derived Peptides

  Wed, 20 Jan 2021 18:00:00 GMTBy:

  In our previous blog post (How to screen SARS-CoV-2 peptides to facilitate T cell research) we have described how the immune system samples all of the pathogenic proteins by looking at the small fragments of each protein and making a determination on whether that fragment (also referred to as peptide) belongs in the body. Read more

• How to Identify SARS-CoV-2 Virus Derived Peptides

  Thu, 19 Nov 2020 17:00:00 GMTBy:

  In our previous blog post (How to screen SARS-CoV-2 peptides to facilitate T cell research) we have described how the immune system samples all of the pathogenic proteins by looking at the small fragments of each protein and making a determination on whether that fragment (also referred to as peptide) belongs in the body. We have also described in our previous blog post (Find Human MHC Class I Dominant Peptides) the multiple MHC alleles that we tested for their ability to present SARS-CoV-2 peptides. Read more

• Find Human MHC Class I Dominant Peptides

  Wed, 28 Oct 2020 16:00:00 GMTBy:

  In our previous blog post (How to screen SARS-CoV-2 peptides to facilitate T cell research) we have described how the immune system samples all of the pathogenic proteins by looking at the small fragments of each protein and making a determination on whether that fragment (also referred to as peptide) belongs in the body. Not all peptides are presented equally and most of the amino acids that make up the proteins of the pathogen remain completely invisible to our immune system. One way the immune system can expand its ability to sample a larger variety of pathogen-derived peptide fragments is to have multiple varieties of MHC molecules each geared to detect a certain type of peptide. Read more

View All

• Share your review – write about your experience using an MBLI product and receive an award. Terms and Conditions apply.

MBL International is here to work with you and advance your unique research needs using custom services. We can help with Immuno-monitoring services using MHC Tetramers and Cytokines.  Contact us today for more information.